Drug · DIN 02237367
ACCURETIC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 5, 2024; first marketed October 1, 1998.
- Drug Identification Number (DIN)
- 02237367
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Quinapril and diuretics C09BA06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| QUINAPRIL (QUINAPRIL HYDROCHLORIDE) | 10 MG | |
| HYDROCHLOROTHIAZIDE | 12.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 18, 2001: NOC 2541New Drug Submission (NDS) · Manufacturer name change
- March 1, 1998: NOC 3136New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “accuretic”. A notice may cover another product or only some lots: read it to see what it covers.
- Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurityApril 21, 2022 · Drugs · Contamination
- Accuretic (quinapril hydrochloride and hydrochlorothiazide): Nitrosamine ImpurityMarch 4, 2022 · Drugs · Contamination · Type I
Other DINs named ACCURETIC
- DIN 02237368 · Cancelled Post Market
- DIN 02237369 · Cancelled Post Market